Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Systemic sclerosis (SSc) is an autoimmune fibrotic disease whose pathogenesis is poorly understood and lacks effective therapies. We undertook quantitative analyses of T cell infiltrates in the skin of 35 untreated patients with early diffuse SSc and here show that CD4+ cytotoxic T cells and CD8+ T cells contribute prominently to these infiltrates. We also observed an accumulation of apoptotic cells in SSc tissues, suggesting that recurring cell death may contribute to tissue damage and remodeling in this fibrotic disease. HLA-DR-expressing endothelial cells were frequent targets of apoptosis in SSc, consistent with the prominent vasculopathy seen in patients with this disease. A circulating effector population of cytotoxic CD4+ T cells, which exhibited signatures of enhanced metabolic activity, was clonally expanded in patients with systemic sclerosis. These data suggest that cytotoxic T cells may induce the apoptotic death of endothelial and other cells in systemic sclerosis. Cell loss driven by immune cells may be followed by overly exuberant tissue repair processes that lead to fibrosis and tissue dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224
Denton, C. P., & Khanna, D. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30933-9 · Cited by 2,212
Self-citationLederer, D. J., & Martinez, F. J. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1705751 · Cited by 2,056 · cited 1×
“Apoptotic death in the lung resulting from germline mutations has also been postulated to contribute to the fibrotic process in idiopathic pulmonary fibrosis (55).”
BackgroundKamisawa, T., Zen, Y., Pillai, S., & Stone, J. H. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60720-0 · Cited by 1,212
Self-citationRituximab for IgG4-related disease: a prospective, open-label trial
Carruthers, M. N., Topazian, M. D., Khosroshahi, A., Witzig, T. E., Wallace, Z. S., Hart, P. A., Deshpande, V., Smyrk, T. C., Chari, S., & Stone, J. H. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206605 · Cited by 726 · cited 1×
“To explore this, we examined pre- and post-treatment skin biopsies of four patients with early diffuse SSc who were enrolled in the ASSET trial examining the efficacy of CTLA4-Ig in SSc (46).”
BackgroundSelf-citationMyeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
Sullivan, K. M., Goldmuntz, E. A., Keyes-Elstein, L., McSweeney, P. A., Pinckney, A., Welch, B., Mayes, M. D., Nash, R. A., Crofford, L. J., Eggleston, B., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1703327 · Cited by 603
Self-citationBurt, R. K., Shah, S. J., Dill, K., Grant, T., Gheorghiade, M., Schroeder, J., Craig, R., Hirano, I., Marshall, K., Ruderman, E., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60982-3 · Cited by 578 · cited 1×
“Arthritis Rheumatol 2018;70(7):1133–1143.”
Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells
Bosurgi, L., Cao, Y. G., Cabeza-Cabrerizo, M., Tucci, A., Hughes, L. D., Kong, Y., Weinstein, J. S., Licona-Limon, P., Schmid, E. T., Pelorosso, F., et al. (2017) · Science · doi:10.1126/science.aai8132 · Cited by 560 · cited 1×
“Although fibrosis is generally considered to be linked to inflammatory cytokines, apoptotic cells have been shown to trigger TAM family kinases on macrophages and thus accelerate wound healing (54).”
BackgroundClonal expansion of CD4+ cytotoxic T lymphocytes in patients with IgG4-related disease
Mattoo, H., Mahajan, V. S., Maehara, T., Deshpande, V., Della-Torre, E., Wallace, Z. S., Kulikova, M., Drijvers, J. M., Daccache, J., Carruthers, M. N., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1330 · Cited by 406 · cited 20×
“IgG4-RD is also a chronic, immune-mediated fibrotic disorder characterized by inflammatory tumor-like masses with a predilection for the lacrimal glands, salivary glands, pancreas, bile ducts, and retroperitoneal tissues (25).”
BackgroundMethodResultSelf-citationSequential dermal microvascular and perivascular changes in the development of scleroderma
Prescott, R. J., Freemont, A. J., Jones, C. J. P., Hoyland, J., & Fielding, P. (1992) · The Journal of Pathology · doi:10.1002/path.1711660307 · Cited by 391 · cited 1×
“T cells are present in SSc tissues and have been postulated to drive both the endothelial dysfunction and the fibrotic pathology of this disease, presumably via the secretion of cytokines that eventually contribute to the activation of macrophages, fibroblasts, and myofibroblasts (10).”
Background
Cited by
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
Oh, D. Y., & Fong, L. (2021) · Immunity · doi:10.1016/j.immuni.2021.11.015 · Cited by 467
“Inflamed skin lesions from systemic sclerosis patients are also infiltrated by GZMA+ CD4+ T cells, which can be seen directly encountering human leukocyte antigen (HLA)-DR+ endothelial cells undergoing apoptosis, suggesting a direct cytotoxic role in end-organ tissue damage (Maehara et al., 2020).”
IgG4-related disease: an update on pathophysiology and implications for clinical care
Perugino, C. A., & Stone, J. H. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0500-7 · Cited by 421
Self-citationTumor-specific cytolytic CD4 T cells mediate immunity against human cancer
Cachot, A., Bilous, M., Liu, Y.-C., Li, X., Saillard, M., Cenerenti, M., Rockinger, G. A., Wyss, T., Guillaume, P., Schmidt, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe3348 · Cited by 328
Wang, Y., Chen, Z., Wang, T., Guo, H., Liu, Y., Dang, N., Hu, S., Wu, L., Zhang, C., Ye, K., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00615-2 · Cited by 82
T-Cell Aging-Associated Phenotypes in Autoimmune Disease
Zhao, T. V., Sato, Y., Goronzy, J. J., & Weyand, C. M. (2022) · Frontiers in Aging · doi:10.3389/fragi.2022.867950 · Cited by 50
Metadata
- Authors
- Maehara, T., Kaneko, N., Perugino, C. A., Mattoo, H., Kers, Allard-Chamard, H., Mahajan, V. S., Liu, H., Murphy, S. J. H., Ghebremichael, M., Fox, D., Payne, A. S., Lafyatis, R., Stone, J. H., Khanna, D., & Pillai, S.
- Venue
- Journal of Clinical Investigation
- Published
- 2020-04-06
- Volume
- 130
- Issue
- 5
- Pages
- 2451-2464
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W3003611811
- Cited by
- 192
- References
- 60
- FWCI
- 14.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.